Yue, J., Lv, D., Wang, C., Li, L., Zhao, Q., Chen, H., & Xu, L. (2018). Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3. Oncogene.

Yue, Jinnan, Dacheng Lv, Caiyun Wang, Ling Li, Qingnan Zhao, Hongzhuan Chen, et Lu Xu. "Epigenetic Silencing of MiR-483-3p Promotes Acquired Gefitinib Resistance and EMT in EGFR-mutant NSCLC By Targeting Integrin β3." Oncogene 2018.

Yue, Jinnan, et al. "Epigenetic Silencing of MiR-483-3p Promotes Acquired Gefitinib Resistance and EMT in EGFR-mutant NSCLC By Targeting Integrin β3." Oncogene 2018.